Pennsylvania cut Medicaid GLP‑1s in 2026, leaving 54,800 without access
A January 2026 Medicaid policy change removed GLP‑1 weight‑loss drugs from coverage, saving the state hundreds of millions but cutting access for 54,800 recipients; lawmakers are proposing a subscription model to restore benefits.
Oprah Winfrey, Shaquille O’Neal, Charles Barkley and even Elon Musk have credited GLP-1s like Ozempic as vital tools in their weight-loss journeys. Influencers, celebrities and healthcare professionals are being paid millions to promote GLP-1s, which have been shown to be effective at treating obesity.